Vol 31 | Issue 1 | Jan – Jun 2018 | page: 35-40 | P S John, Varghese Thomas
Authors: P S John [1], Varghese Thomas [1]
[1] Department of Orthopaedics, Pushpagiri Institute of Medical Science & Research, Thiruvalla.
Address of Correspondence
Dr. P S John,
Department of Orthopaedics, Pushpagiri Institute of Medical Science & Research, Thiruvalla.
Email:drpsjohn@gmail.com
Abstract
Osteoarthrosis (OA), the most common joint disorder, produces a tremendous burden on healthcare systems throughout the world. Since there is no effective cure, OA represents a unique opportunity for innovation in the development of treatment strategy. In contrast to traditional treatments with drugs, proteins or anti bodies, stem cells are expected to revolutionize the treatment of many degenerative diseases including osteoarthrosis. There are ongoing debates whether stem cells can be effective in the treatment of complex diseases like osteoarthrosis. In this review the application of various methods for cartilage regeneration using stem cells in the treatment of osteoarthrosis is discussed. It is suggested that further investigations into new treatment strategies or combination therapies might provide useful treatment options in the management of osteoarthrosis. It is very important to evaluate the safety and effectiveness of cell based therapy before clinical use. This review provides updated information on recent clinical trials and related applications of stem cells in cartilage regeneration, there by opening up new treatment horizons in the management of osteoarthrosis.
Keywords: Cartilage, regeneration, chondrocyte, stem cells..
References
1. Di Martino A, Kon E, Perdisa F, Sessa A, Filardo G, Neri MP, Bragonzoni L, Marcacci M. Surgical treatment of early knee osteoarthritis with a cell-free osteochondral scaffold: results at 24 months of follow-up. Injury. 2015;46 Suppl 8:S33–8.
2. Kon E, Filardo G, Drobnic M, Madry H, Jelic M, van Dijk N, Della Villa S. Nonsurgical management of early knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2012;20:436–49.
3. Wittenauer R, Smith L, Aden K. Background paper 6.12 osteoarthritis. Geneva: World Health Organization; 2013.
4. Birchfield PC. Osteoarthritis overview. Geriatr Nurs 2001;223:124-30.
5. Arden N, Cooper C. Osteoarthritis handbook. Osteoarthritis: epidemiology. London: Informa Healthcare; 2005.
6. Zhen G, Wen C, Jia X, Li Y, Crane JL, Mears SC, et al. Inhibition of TGF-beta signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med 2013; 196:704e12.
7. Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med 2007;132:156e63.
8. Hayami T, Pickarski M, Wesolowski GA, McLane J, Bone A, Destefano J, et al. The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum 2004;504:1193-206.
9. Wen C, Lu WW, Chiu KY. Importance of subchondral bone in the pathogenesis and management of osteoarthritis from bench to bed. J Orthop Transl 2014;21:16e25.
10. Sharma L, Berenbaum F. Osteoarthritis: a companion to rheumatology. Amsterdam: Elsevier Health Sciences; 2007.
11. Sarzi-Puttini P, Cimmino MA, Scarpa R, Caporali R, Parazzini F, Zaninelli A, et al. Osteoarthritis: an overview of the disease and its treatment strategies. Semin Arthritis Rheum 2005;351:1e10.
12. Noth U, Steinert AF, Tuan RS. Technology insight: adult mesenchymal stem cells for osteoarthritis therapy. Nat Clin Pract Rheumatol 2008;47:371e80.
13. Barry F, Murphy M. Mesenchymal stem cells in joint disease and repair. Nat Rev Rheumatol 2013;910:584e94.
14. Kon E, Filardo G, Roffi A, Andriolo L, Marcacci M. New trends for knee cartilage regeneration: from cell-free scaffolds to mesenchymal stem cells. Curr Rev Musculoskelet Med. 2012;5:236–43.
15. Filardo G, Madry H, Jelic M, Roffi A, Cucchiarini M, Kon E. Mesenchymal stem cells for the treatment of cartilage lesions: from preclinical findings to clinical application in orthopaedics. Knee Surg Sports Traumatol Arthrosc. 2013;21:1717–29.
16. Manferdini C, Maumus M, Gabusi E, Piacentini A, Filardo G, Peyrafitte JA, Jorgensen C, Bourin P, Fleury-Cappellesso S, Facchini A, et al. Adiposederived mesenchymal stem cells exert antiinflammatory effects on chondrocytes and synoviocytes from osteoarthritis patients through prostaglandin E2. Arthritis Rheum. 2013;65:1271–81.
17. Caplan AI. All MSCs are pericytes? Cell Stem Cell. 2008;3:229–30.
18. Perdisa F, Gostynska N, Roffi A, Filardo G, Marcacci M, Kon E. Adiposederived mesenchymal stem cells for the treatment of articular cartilage: a systematic review on preclinical and clinical evidence. Stem Cells Int. 2015;2015:597652.
19. Ahmed TA, Hincke MT. Mesenchymal stem cell-based tissue engineering strategies for repair of articular cartilage. Histol Histopathol. 2014;29:669–89.
20. Stevens MM. Biomaterials for bone tissue engineering. Mater Today 2008;115:18e25.
21. Bhardwaj N, Kundu SC. Chondrogenic differentiation of rat MSCs on porous scaffolds of silk fibroin/chitosan blends. Biomaterials 2012;3310:2848-57.
22. Awad HA, Wickham MQ, Leddy HA, Gimble JM, Guilak F. Chondrogenic differentiation of adipose-derived adult stem cells in agarose, alginate, and gelatin scaffolds. Biomaterials 2004;2516:3211e22.
23. Huang CYC, Reuben PM, D’Ippolito G, Schiller PC, Cheung HS. Chondrogenesis of human bone marrow-derived mesenchymal stem cells in agarose culture. Anat Rec A Discov Mol Cell Evol Biol 2004;278A1:428e36.
24. Kundu B, Kundu SC. Silk sericin/polyacrylamide in situ forming hydrogels for dermal reconstruction. Biomaterials 2012;3330:7456e67.
25. Teixeira LSM, Feijen J, van Blitterswijk CA, Dijkstra PJ, Karperien M. Enzyme-catalyzed crosslinkable hydrogels: emerging strategies for tissue engineering. Biomaterials 2012;335:1281e90.
26. Williams CG, Kim TK, Taboas A, Malik A, Manson P, Elisseeff J. In vitro chondrogenesis of bone marrow-derived mesenchymal stem cells in a photopolymerizing hydrogel. Tissue Eng 2003;94:679e88.
27. Niamsa N, Srisuwan Y, Baimark Y, Phinyocheep P, Kittipoom S. Preparation of nanocomposite chitosan/silk fibroin blend films containing nanopore structures. Carbohydr Polym 2009;781:60e5.
28. Re’em T, Kaminer-Israeli Y, Ruvinov E, Cohen S. Chondrogenesis of hMSC in affinity-bound TGF-beta scaffolds. Biomaterials 2012;333:751e61.
29. FDA News Release. FDA approves first autologous cellularized scaffold for the repair of cartilage defects of the knee. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm533153.htm.
30. ter Huurne M, Schelbergen R, Blattes R, Blom A, de Munter W, Grevers LC, et al. Antiinflammatory and chondroprotective effects of intraarticular injection of adiposederived stem cells in experimental osteoarthritis. Arthritis Rheum 2012;6411:3604e13.
31. Wakitani S, Goto T, Pineda SJ, Young RG, Mansour JM, Caplan AI, et al. Mesenchymal cell-based repair of large, fullthickness defects of articular cartilage. J Bone Jt Surg Am 1994;76:579e92.
32. Toghraie F, Razmkhah M, Gholipour MA, Faghih Z, Chenari N, Nezhad ST, et al. Scaffold-free adipose-derived stem cells (ASCs) improve experimentally induced osteoarthritis in rabbits. Arch Iran Med 2012;158:495e9.
33. Murphy JM, Fink DJ, Hunziker EB, Barry FP. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 2003; 4812:3464e74.
34. Frisbie DD, Kisiday JD, Kawcak CE, Werpy NM, Mcllwraith CW. Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis. J Orthop Res 2009;2712:1675e80.
35. Sato M, Uchida K, Nakajima H, Miyazaki T, Guerrero AR, Watanabe S, et al. Direct transplantation of mesenchymal stem cells into the knee joints of Hartley strain guinea pigs with spontaneous osteoarthritis. Arthritis Res Ther 2012;14:
36. Diekman BO, Wu CL, Louer CR, Furman BD, Huebner JL, Kraus VB, et al. Intra-articular delivery of purified mesenchymal stem cells from C57BL/6 or MRL/MpJ superhealer mice prevents posttraumatic arthritis. Cell Transpl 2013;228: 1395e408.
37. Horie M, Driscoll MD, Sampson HW, Sekiya I, Caroom CT, Prockop DJ, et al. Implantation of allogenic synovial stem cells promotes meniscal regeneration in a rabbit meniscal defect model. J Bone Jt Surg Am 2012;948:701e12.
38. Al Faqeh H, Nor Hamdan BM, Chen HC, Aminuddin BS,Ruszymah BH. The potential of intra-articular injection of chondrogenic-induced bone marrow stem cells to retard the progression of osteoarthritis in a sheep model. Exp Gerontol 2012;476:458-64.
39. Horie M, Sekiya I, Muneta T, Ichinose S, Matsumoto K, Saito H, et al. Intra-articular injected synovial stem cells differentiate into meniscal cells directly and promote meniscal regeneration without mobilization to distant organs in rat massive meniscal defect. Stem Cells 2009;274: 878e87.
40. Lee KBL, Hui JHP, Song IC, Ardany L, Lee EH. Injectable mesenchymal stem cell therapy for large cartilage defectsda porcine model. Stem Cells 2007;2511:2964e71.
41. Mokbel AN, El Tookhy OS, Shamaa AA, Rashed LA, Sabry D, El Sayed AM. Homing and reparative effect of intraarticular injection of autologus mesenchymal stem cells in osteoarthritic animal model. BMC Musculoskelet Disord 2011;12:259.
42. Chen D, Shen J, Zhao W, Wang T, Han L, Hamilton JL, et al. Osteoarthritis: toward a comprehensive understanding of pathological mechanism. Bone Res 2017;5:16044.
43. Mokbel AN, El Tookhy OS, Shamaa AA, Rashed LA, Sabry D, El Sayed AM. Homing and reparative effect of intraarticular injection of autologus mesenchymal stem cells in osteoarthritic animal model. BMC Musculoskelet Disord 2011;12:259.
44. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994;33114:889e95.
45. Wakitani S, Yamamoto T. Response of the donor and recipient cells in mesenchymal cell transplantation to cartilage defect. Microsc Res Tech 2002;581:14e8.
46. Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N, Yoneda M. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthr Cartil 2002;103: 199e206.
47. Wakitani S, Nawata M, Tensho K, Okabe T, Machida H, Ohgushi H. Repair of articular cartilage defects in the patellofemoral joint with autologous bone marrow mesenchymal cell transplantation: three case reports involving nine defects in five knees. J Tissue Eng Regen Med 2007;11:74e9.
48. Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, Karli D. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician 2008;113:343e53.
49. Emadedin M, Aghdami N, Taghiyar L, Fazeli R, Moghadasali R, Jahangir S, et al. Intra-articular injection of autologous mesenchymal stem cells in six patients with knee osteoarthritis. Arch Iran Med 2012;157:422e8.
50. Jo CH, Lee YG, Shin WH, Kim H, Chai JW, Jeong EC, et al. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial. Stem Cells 2014;325:1254-66..
How to Cite this Article: John P S, Thomas V. Articular cartilage regeneration in the treatment of osteoarthrosis. Kerala Journal of Orthopaedics Jan- Jun 2018;31(1):35-40 .
|